Literature DB >> 26063186

Anti-Citrullinated Protein Antibodies Induce Macrophage Subset Disequilibrium in RA Patients.

Wei Zhu1,2,3, Xiu Li4, Shaohong Fang5,3, Xiaoli Zhang2, Ying Wang4, Tongshuai Zhang1, Zhaoying Li1, Yanwen Xu1, Siying Qu1, Chuanliang Liu1, Fei Gao6, Haile Pan7, Guangyou Wang1, Hulun Li8,9, Bo Sun10,11.   

Abstract

We used samples from rheumatoid arthritis (RA) patients to examine whether Anti-citrullinated protein antibodies (ACPAs) alter macrophage subset distribution and promote RA development. Macrophage subset distributions and interferon regulatory factor 4 (IRF4) and IRF5 expressions were analyzed. ACPAs were purified by affinity column. After RA and osteoarthritis (OA) patients' macrophages were cocultured with ACPAs, macrophage subsets and IRF4 and IRF5 expressions were measured. Small interfering RNAs (siRNAs) were transfected into ACPA-activated cells to suppress IRF4 or IRF5. Fluorescence-activated cell sorting (FACS), Western blot, and immunohistochemistry were performed. Macrophage subset disequilibrium occurred in RA patient synovial fluids. IRF4 and IRF5 were all expressed in the synovial fluid and synovium. ACPAs (40 IU/ml) could induce macrophages to polarize to M1 subsets, and the percentage of increased M1/M2 ratio of RA patients was higher than that of the OA patients. ACPAs also induce IRF4 and IRF5 protein expressions. IRF5 siRNA transfection impaired ACPA activity significantly. We demonstrated that macrophage subset disequilibrium occurred in RA patients. ACPAs induced IRF5 activity and led to M1 macrophage polarization.

Entities:  

Keywords:  ACPAs; IRF5; macrophage subset; rheumatoid arthritis

Mesh:

Substances:

Year:  2015        PMID: 26063186     DOI: 10.1007/s10753-015-0188-z

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  32 in total

1.  Treatment of arthritis by macrophage depletion and immunomodulation: testing an apoptosis-mediated therapy in a humanized death receptor mouse model.

Authors:  Jun Li; Hui-Chen Hsu; PingAr Yang; Qi Wu; Hao Li; Laura E Edgington; Matthew Bogyo; Robert P Kimberly; John D Mountz
Journal:  Arthritis Rheum       Date:  2011-10-13

2.  Fibrin deimination in synovial tissue is not specific for rheumatoid arthritis but commonly occurs during synovitides.

Authors:  Sabine Chapuy-Regaud; Mireille Sebbag; Dominique Baeten; Cyril Clavel; Céline Foulquier; Filip De Keyser; Guy Serre
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

Review 3.  Regulation of immunity and oncogenesis by the IRF transcription factor family.

Authors:  David Savitsky; Tomohiko Tamura; Hideyuki Yanai; Tadatsugu Taniguchi
Journal:  Cancer Immunol Immunother       Date:  2010-01-05       Impact factor: 6.968

4.  IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses.

Authors:  Thomas Krausgruber; Katrina Blazek; Tim Smallie; Saba Alzabin; Helen Lockstone; Natasha Sahgal; Tracy Hussell; Marc Feldmann; Irina A Udalova
Journal:  Nat Immunol       Date:  2011-01-16       Impact factor: 25.606

5.  Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors.

Authors:  Akinori Takaoka; Hideyuki Yanai; Seiji Kondo; Gordon Duncan; Hideo Negishi; Tatsuaki Mizutani; Shin-Ichi Kano; Kenya Honda; Yusuke Ohba; Tak W Mak; Tadatsugu Taniguchi
Journal:  Nature       Date:  2005-01-23       Impact factor: 49.962

6.  Disequilibrium of M1 and M2 macrophages correlates with the development of experimental inflammatory bowel diseases.

Authors:  Wei Zhu; Jianbo Yu; Ying Nie; XueKui Shi; Yang Liu; Fujuan Li; Xiao-li Zhang
Journal:  Immunol Invest       Date:  2014-06-12       Impact factor: 3.657

7.  Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity.

Authors:  Leen De Rycke; Anthony P Nicholas; Tineke Cantaert; Elli Kruithof; Joshua D Echols; Bart Vandekerckhove; Eric M Veys; Filip De Keyser; Dominique Baeten
Journal:  Arthritis Rheum       Date:  2005-08

Review 8.  Macrophages in rheumatoid arthritis.

Authors:  N Maruotti; F P Cantatore; E Crivellato; A Vacca; D Ribatti
Journal:  Histol Histopathol       Date:  2007-05       Impact factor: 2.303

9.  Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis.

Authors:  Kristine A Kuhn; Liudmila Kulik; Beren Tomooka; Kristin J Braschler; William P Arend; William H Robinson; V Michael Holers
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

10.  Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages.

Authors:  E R Vossenaar; T R D Radstake; A van der Heijden; M A M van Mansum; C Dieteren; D-J de Rooij; P Barrera; A J W Zendman; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

View more
  16 in total

Review 1.  Arthritis models: usefulness and interpretation.

Authors:  Natacha Bessis; Patrice Decker; Eric Assier; Luca Semerano; Marie-Christophe Boissier
Journal:  Semin Immunopathol       Date:  2017-03-27       Impact factor: 9.623

Review 2.  Interferon regulatory factor signaling in autoimmune disease.

Authors:  Bharati Matta; Su Song; Dan Li; Betsy J Barnes
Journal:  Cytokine       Date:  2017-03-07       Impact factor: 3.861

Review 3.  Macrophages: The Good, the Bad, and the Gluttony.

Authors:  Ewan A Ross; Andrew Devitt; Jill R Johnson
Journal:  Front Immunol       Date:  2021-08-12       Impact factor: 7.561

4.  Rheumatoid arthritis CD14+ monocytes display metabolic and inflammatory dysfunction, a phenotype that precedes clinical manifestation of disease.

Authors:  Trudy McGarry; Megan M Hanlon; Viviana Marzaioli; Clare C Cunningham; Vinod Krishna; Kieran Murray; Conor Hurson; Phil Gallagher; Sunil Nagpal; Douglas J Veale; Ursula Fearon
Journal:  Clin Transl Immunology       Date:  2021-01-19

Review 5.  Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis.

Authors:  Anca Catrina; Akilan Krishnamurthy; Bence Rethi
Journal:  RMD Open       Date:  2021-03

6.  Iguratimod promotes transformation of mononuclear macrophages in elderly patients with rheumatoid arthritis by nuclear factor-κB pathway.

Authors:  Sha Liu; Li-Ping Song; Rong-Bin Li; Le-Heng Feng; Hui Zhu
Journal:  World J Clin Cases       Date:  2021-04-06       Impact factor: 1.337

7.  Spermidine Inhibits Joints Inflammation and Macrophage Activation in Mice with Collagen-Induced Arthritis.

Authors:  Hao Yuan; Si-Xian Wu; Yi-Feng Zhou; Fang Peng
Journal:  J Inflamm Res       Date:  2021-06-24

8.  IRAK4 inhibition: a promising strategy for treating RA joint inflammation and bone erosion.

Authors:  Sadiq Umar; Karol Palasiewicz; Katrien Van Raemdonck; Michael V Volin; Bianca Romay; M Asif Amin; Ryan K Zomorrodi; Shiva Arami; Mark Gonzalez; Vikram Rao; Brian Zanotti; David A Fox; Nadera Sweiss; Shiva Shahrara
Journal:  Cell Mol Immunol       Date:  2020-05-15       Impact factor: 22.096

Review 9.  Emerging role of targeting macrophages in rheumatoid arthritis: Focus on polarization, metabolism and apoptosis.

Authors:  Xuezhi Yang; Yan Chang; Wei Wei
Journal:  Cell Prolif       Date:  2020-06-12       Impact factor: 6.831

10.  Chemokine Receptor 5 Antagonism Causes Reduction in Joint Inflammation in a Collagen-Induced Arthritis Mouse Model.

Authors:  Mushtaq A Ansari; Ahmed Nadeem; Saleh A Bakheet; Sabry M Attia; Mudassar Shahid; Faris S Alyousef; Mohammed A Alswailem; Mohammed Alqinyah; Sheikh F Ahmad
Journal:  Molecules       Date:  2021-03-25       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.